Grace Larry
Directeur/Membre du Conseil chez Generate Biomedicines, Inc.
Profil
Grace Larry is currently a Senior Director at Generate Biomedicines, Inc. and a Venture Partner at Alix Ventures.
Prior to his current roles, he worked as an Executive Director at Amgen, Inc. from 2019 to 2021 and as a Director-Asia Operations at Novartis AG from 2011 to 2013.
Mr. Larry has a graduate degree from the University of California, Berkeley, an MBA from Kellogg School of Management, and a graduate degree from Northwestern University School of Law.
Postes actifs de Grace Larry
| Sociétés | Poste | Début |
|---|---|---|
Alix Ventures
 Alix Ventures Investment ManagersFinance Alix Ventures is an venture capital firm founded in 2019 by Chas Pulido. The firm is headquartered in San Francisco, California. | Private Equity Investor | - |
Generate Biomedicines, Inc.
 Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | Directeur/Membre du Conseil | 01/07/2021 |
Anciens postes connus de Grace Larry
| Sociétés | Poste | Fin |
|---|---|---|
| AMGEN INC. | Directeur/Membre du Conseil | 01/04/2021 |
| NOVARTIS AG | Corporate Officer/Principal | 01/04/2013 |
Formation de Grace Larry
| Northwestern University School of Law | Graduate Degree |
| Kellogg School of Management | Masters Business Admin |
| University of California, Berkeley | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| NOVARTIS AG | Health Technology |
| Entreprise privées | 2 |
|---|---|
Alix Ventures
Alix Ventures Investment ManagersFinance Alix Ventures is an venture capital firm founded in 2019 by Chas Pulido. The firm is headquartered in San Francisco, California. | Finance |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | Health Technology |